These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31114586)

  • 1. TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes.
    Staniek J; Lorenzetti R; Heller B; Janowska I; Schneider P; Unger S; Warnatz K; Seidl M; Venhoff N; Thiel J; Smulski CR; Rizzi M
    Front Immunol; 2019; 10():951. PubMed ID: 31114586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
    Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P
    J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma.
    Zhang XD; Franco A; Myers K; Gray C; Nguyen T; Hersey P
    Cancer Res; 1999 Jun; 59(11):2747-53. PubMed ID: 10364001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2.
    Sprick MR; Weigand MA; Rieser E; Rauch CT; Juo P; Blenis J; Krammer PH; Walczak H
    Immunity; 2000 Jun; 12(6):599-609. PubMed ID: 10894160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D.
    Olsson A; Diaz T; Aguilar-Santelises M; Osterborg A; Celsing F; Jondal M; Osorio LM
    Leukemia; 2001 Dec; 15(12):1868-77. PubMed ID: 11753607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells.
    Willms A; Schittek H; Rahn S; Sosna J; Mert U; Adam D; Trauzold A
    PLoS One; 2019; 14(4):e0214847. PubMed ID: 30947287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of tumor necrosis factor related apoptosis-inducing ligand (TRAIL) receptors in a human osteoclast model in vitro.
    McManus S; Chamoux E; Bisson M; Roux S
    Apoptosis; 2012 Feb; 17(2):121-31. PubMed ID: 21972115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of tumor necrosis factor-related apoptosis-inducing ligand on developing human oligodendrocytes in culture].
    Xiao ML; Liu JQ; Chen C
    Mol Biol (Mosk); 2014; 48(6):963-9. PubMed ID: 25845236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2) induces apoptosis in primary renal cell carcinoma cells in vitro and inhibits tumor growth in vivo.
    Zeng Y; Wu XX; Fiscella M; Shimada O; Humphreys R; Albert V; Kakehi Y
    Int J Oncol; 2006 Feb; 28(2):421-30. PubMed ID: 16391797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of TRAIL receptors using monoclonal antibodies.
    Griffith TS; Rauch CT; Smolak PJ; Waugh JY; Boiani N; Lynch DH; Smith CA; Goodwin RG; Kubin MZ
    J Immunol; 1999 Mar; 162(5):2597-605. PubMed ID: 10072501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of the expression of CD95 ligand, receptor activator of nuclear factor-kappa B ligand (RANKL), TNF-related apoptosis-inducing ligand (TRAIL), and TNF-alpha during T cell activation.
    Wang R; Zhang L; Zhang X; Moreno J; Luo X; Tondravi M; Shi Y
    J Immunol; 2001 Feb; 166(3):1983-90. PubMed ID: 11160247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity.
    Wuchter C; Krappmann D; Cai Z; Ruppert V; Scheidereit C; Dörken B; Ludwig WD; Karawajew L
    Leukemia; 2001 Jun; 15(6):921-8. PubMed ID: 11417478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte expression of TRAIL pathway regulators correlates with histopathological and clinical parameters in chronic HCV infection.
    Brost S; Zimmermann A; Koschny R; Sykora J; Stremmel W; Schirmacher P; Walczak H; Ganten TM
    Pathol Res Pract; 2014 Feb; 210(2):83-91. PubMed ID: 24268735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
    J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restricted expression of tumor necrosis factor-related apoptosis-inducing ligand receptor 4 in human peripheral blood lymphocytes.
    Hasegawa H; Yamada Y; Harasawa H; Tsuji T; Murata K; Sugahara K; Tsuruda K; Masuda M; Takasu N; Kamihira S
    Cell Immunol; 2004; 231(1-2):1-7. PubMed ID: 15919363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue distribution of the death ligand TRAIL and its receptors.
    Spierings DC; de Vries EG; Vellenga E; van den Heuvel FA; Koornstra JJ; Wesseling J; Hollema H; de Jong S
    J Histochem Cytochem; 2004 Jun; 52(6):821-31. PubMed ID: 15150291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-related apoptosis-inducing ligand: signalling of a 'smart' molecule.
    Manzo F; Nebbioso A; Miceli M; Conte M; De Bellis F; Carafa V; Franci G; Tambaro FP; Altucci L
    Int J Biochem Cell Biol; 2009 Mar; 41(3):460-6. PubMed ID: 18243765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
    Söderström TS; Poukkula M; Holmström TH; Heiskanen KM; Eriksson JE
    J Immunol; 2002 Sep; 169(6):2851-60. PubMed ID: 12218097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3.
    Perlman H; Nguyen N; Liu H; Eslick J; Esser S; Walsh K; Moore TL; Pope RM
    Arthritis Rheum; 2003 Nov; 48(11):3096-101. PubMed ID: 14613271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes.
    Leverkus M; Neumann M; Mengling T; Rauch CT; Bröcker EB; Krammer PH; Walczak H
    Cancer Res; 2000 Feb; 60(3):553-9. PubMed ID: 10676636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.